TD Private Client Wealth LLC Reduces Stock Holdings in Kenvue Inc. $KVUE

TD Private Client Wealth LLC reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 80.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 51,993 shares of the company’s stock after selling 219,209 shares during the quarter. TD Private Client Wealth LLC’s holdings in Kenvue were worth $844,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in KVUE. Renaissance Capital LLC grew its holdings in Kenvue by 8.3% during the second quarter. Renaissance Capital LLC now owns 629,177 shares of the company’s stock valued at $13,169,000 after purchasing an additional 48,267 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Kenvue by 80.7% during the 2nd quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock valued at $758,000 after buying an additional 16,164 shares in the last quarter. Arlington Partners LLC purchased a new position in shares of Kenvue during the 2nd quarter valued at about $2,110,000. Cornell Pochily Investment Advisors Inc. grew its stake in shares of Kenvue by 144.6% during the 2nd quarter. Cornell Pochily Investment Advisors Inc. now owns 33,173 shares of the company’s stock valued at $694,000 after acquiring an additional 19,609 shares during the period. Finally, TrueMark Investments LLC increased its holdings in Kenvue by 8.8% in the 2nd quarter. TrueMark Investments LLC now owns 229,648 shares of the company’s stock worth $4,807,000 after acquiring an additional 18,623 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In other news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction on Friday, December 12th. The shares were acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. The trade was a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.68% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on KVUE. Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a research note on Friday, October 24th. Evercore ISI set a $18.00 price target on Kenvue in a report on Tuesday, October 28th. Finally, UBS Group dropped their price objective on Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $20.23.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $17.27 on Friday. The company has a market cap of $33.08 billion, a P/E ratio of 23.02 and a beta of 0.60. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The firm’s fifty day moving average is $16.97 and its two-hundred day moving average is $18.31.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. During the same quarter in the prior year, the firm earned $0.28 EPS. The business’s revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.8%. The ex-dividend date was Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.